Results 191 to 200 of about 19,210 (233)
Evaluation of the therapeutic effects of smoking cessation on chronic central serous chorioretinopathy. [PDF]
Nagata T +7 more
europepmc +1 more source
Evaluation of anterior scleral thickness in eyes with central serous chorioretinopathy. [PDF]
Prabhakaran P +7 more
europepmc +1 more source
Central serous chorioretinopathy mimicking as choroidal hemangioma - A diagnostic challenge.
Singh S, Sodhi PKS, Tagare S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
American journal of ophthalmology-glaucoma, 2021
PURPOSE To compare the efficacy and safety between half-dose photodynamic therapy (PDT) and eplerenone for treating chronic central serous chorioretinopathy (cCSC). DESIGN Multicenter, open-label, randomized controlled trial.
Thomas J. van Rijssen +9 more
semanticscholar +1 more source
PURPOSE To compare the efficacy and safety between half-dose photodynamic therapy (PDT) and eplerenone for treating chronic central serous chorioretinopathy (cCSC). DESIGN Multicenter, open-label, randomized controlled trial.
Thomas J. van Rijssen +9 more
semanticscholar +1 more source
[Central serous chorioretinopathy].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2021Central serous chorioretinopathy (CSC) is the fourth most common disease of the macula after age-related macular degeneration, diabetic retinopathy and retinal vein occlusion and a cause of irreversible visual loss. This article gives an overview of the epidemiology, risk factors, pathophysiology, clinical presentation, multimodal imaging and discusses
Laurenz, Pauleikhoff +2 more
openaire +3 more sources
REGIONAL SCLERAL THICKNESS AS A RISK FACTOR FOR CENTRAL SEROUS CHORIORETINOPATHY
Retina, 2022Scleral thicknesses of the posterior and equatorial portions of the eye were found to be significant predictors of central serous chorioretinopathy, consistent with what was proposed in the theory of venous overload choroidopathy.
R. Spaide +3 more
semanticscholar +1 more source
SAUSAGING AND BULBOSITIES OF THE CHOROIDAL VEINS IN CENTRAL SEROUS CHORIORETINOPATHY
Retina, 2022Analysis of indocyanine green angiography of eyes with central serous chorioretinopathy showed sausaging of the choroidal veins was common and had a highly significant correlation with the subfoveal choroidal thickness.
R. Spaide +3 more
semanticscholar +1 more source
Melatonin prevents experimental central serous chorioretinopathy in rats
Journal of Pineal Research, 2022Central serous chorioretinopathy (CSC) is a vision‐threatening disease with no validated treatment and unclear pathogenesis. It is characterized by dilation and leakage of choroidal vasculature, resulting in the accumulation of subretinal fluid, and ...
Shanshan Yu +12 more
semanticscholar +1 more source
Quantitative contrast sensitivity test to assess visual function in central serous chorioretinopathy
British Journal of Ophthalmology, 2022Background To characterise the contrast sensitivity function (CSF) in central serous chorioretinopathy (CSCR) compared with healthy controls using novel computerised contrast sensitivity (CS) testing with active learning algorithms.
Filippos Vingopoulos +13 more
semanticscholar +1 more source
Retina, 2022
Photodynamic therapy–induced acute exudative maculopathy was frequent in chronic central serous chorioretinopathy. However, a self-resolving evolution and favorable prognosis were observed in most cases.
J. Fernández-Vigo +5 more
semanticscholar +1 more source
Photodynamic therapy–induced acute exudative maculopathy was frequent in chronic central serous chorioretinopathy. However, a self-resolving evolution and favorable prognosis were observed in most cases.
J. Fernández-Vigo +5 more
semanticscholar +1 more source

